Work

Abstract 5691: Preclinical evaluation of RMC-7977, a multi-selective RAS(ON) inhibitor, as a therapeutic strategy for KRAS-mutant cholangiocarcinoma

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5691

Authors: Rodrigo Entrialgo-Cadierno, Iker Feliu, Ines Lopez, Yaiza Senent, Shruthi Narayanan, Nicole Nasholm, Ruben Pio, Jingjing Jiang, Silvestre Vicent

Institutions: Centro de Investigación Médica Aplicada, Revolution Medicines (United States)

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409632443

Cites:

Cited by:

Related to: 10